{"id":"W4362586002","doi":"10.1016/s1556-0864(23)00258-7","title":"40 Patient-reported outcomes from the CodeBreaK 200 phase III trial comparing sotorasib versus docetaxel in KRAS G12C-mutated NSCLC","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AstraZeneca","keywords":"Docetaxel; Medicine; Common Terminology Criteria for Adverse Events; Visual analogue scale; Quality of life (healthcare); Internal medicine; Clinical endpoint; Adverse effect; Physical therapy; Oncology; Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001511059,0.0008962149,0.001691395,0.0003155665,0.0003767541,0.0009917511,0.0005024188,0.0009786534,0.004841755],"category_scores_gemma":[0.001692573,0.0002953857,0.003928057,0.0004290923,0.0004614647,0.000629311,0.0003431029,0.002802838,0.0007801913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001376216,"about_ca_system_score_gemma":0.0007845011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001773309,"about_ca_topic_score_gemma":0.006328643,"domain_scores_codex":[0.9994186,0.0002633493,0.00004582409,0.0001016525,0.00008554758,0.00008499153],"domain_scores_gemma":[0.9990216,0.0003339342,0.0002329338,0.00006439448,0.00006730821,0.0002798049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8449037,0.005636893,0.01013817,0.002400528,0.01372792,0.0001375787,0.0001247559,0.007326009,0.01077316,0.0004192822,0.01027479,0.0941373],"study_design_scores_gemma":[0.7146345,0.1650899,0.07940707,0.0005238419,0.01720186,0.0004353783,0.0001704472,0.003964788,0.003301376,0.001873203,0.01322756,0.0001699016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9728392,0.01068243,0.0005175583,0.001279981,0.0003998801,0.0009138018,0.007602898,0.00007106712,0.005693107],"genre_scores_gemma":[0.9802746,0.003575357,0.0006742274,0.001649306,0.000268097,0.0008088699,0.008475098,0.00003489947,0.004239576],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004841755,"threshold_uncertainty_score":0.01619726,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08041390054959867,"score_gpt":0.4899498132552781,"score_spread":0.4095359127056795,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}